Phase 3 Trial Shows Lenvatinib Meets Primary Endpoint of Progression Free Survival in Radioiodine-Refractory Differentiated Thyroid Cancer Blog Post
Overuse of Radioactive Iodine to Treat Low-Risk Thyroid Cancer Is Highest in Regions with Poor Health Care Access Blog Post
American Thyroid Association (ATA) Issues Statement On The Potential Risks Of Excess Iodine Ingestion And Exposure Blog Post
Radioactive Iodine Treatment Should Be Used in Some but Not All Cases of Papillary Thyroid Cancer Blog Post
Children, Young Adults Treated with Radioactive Iodine at Elevated Risk of Developing Secondary Primary Cancer Blog Post
Glitazone Pretreatment Can Boost Efficacy of Radioiodine Therapy in Metastatic Thyroid Cancer Blog Post
Iodine Supplementation for Pregnancy and Lactation— United States and Canada: Recommendations of the American Thyroid Association Blog Post